Archivos de Bronconeumologia

Papers
(The H4-Index of Archivos de Bronconeumologia is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs)129
Recall for Medications: The Fragile Balance Risk/Benefit110
Contents58
Cardiac Ultrasound Image Disappearance in the Precordial Area as a New Specific Ultrasound Sign for Diagnosing Neonatal Pneumothorax and Precardiac Thoracentesis Therapy: A Retrospective Case–Control 53
Diffuse Lung and Cardiac Involvement in Alveolar Echinococcus38
Out With the Old, in With the New: What Changes in the 9th Edition of the TNM Classification for Lung Cancer?35
Application of Extracorporeal Membrane Oxygenation Combined With High-flow Nasal Oxygen Therapy in Tracheal Stenosis Reconstructive Surgery: A Case Report34
Shared Vision, Common Future: The Power of Scientific Collaboration33
Are Oxygen and Non-Invasive Ventilation Useful “Clean Doping Boosters” for Thoracoabdominal Asynchrony During Exertion in Severe COPD?30
Disseminated Tuberculosis30
Delayed Presentation of Traumatic Diaphragmatic Rupture With Hemothorax30
Histological Features and Gene Expression Profiling in Lung Transplantation From Donation After Circulatory Death30
Bullous Lung Disease Post-COVID29
A Report on a Targeted Screening Population for Alpha-1-Antitrypsin Deficiency (AATD) in Central-Southern Italy29
Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial28
Bordetella bronchiseptica Pneumonia in an Immunocompetent Young Man28
Invasive Fungal Infections: No Trial, No Error, Just Uncertainty—Immunosuppression Diversifies, but Evidence Remains Anchored in Classical Models27
Electronic Nicotine Delivery Systems: The New Threat27
Changes in Non-invasive Ventilation Compliance in Patients With Amyotrophic Lateral Sclerosis: A Post-hoc Analysis25
Rethinking GOLD E: The Significance of a Single Moderate Exacerbation in COPD25
Real-world Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection Not Associated with Cystic Fibrosis: A Comparative Analysis From the INBREATHING Registry25
Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study24
Nintedanib Combined With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis: A Long-Term Retrospective Multicentre Study (Combi-PF)23
0.12768602371216